Whipplewood Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Whipplewood Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90	Closed	-$2.71K	–	990
2026 Q1	$2.71K	Buy	+90	New	+$2.9K	﹤0.01%	721
2025 Q3	–	Sell	-90	Closed	-$1.51K	–	1065
2025 Q2	$1.51K	Buy	90 +82	+1,025%	+$1.32K	﹤0.01%	936
2025 Q1	$1.38K	Sell	8 -82	-91%	-$1.47K	﹤0.01%	958
2024 Q4	$1.98K	Buy	+90	New	+$1.64K	﹤0.01%	885

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Whipplewood Advisors's TEVA Position: Q2 2026 in Review

Whipplewood Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 90 shares — an estimated $2.71K sold.

Whipplewood Advisors first reported a position in TEVA in Q4 2024 and held it in 4 quarters. The position peaked at $2.71K in Q1 2026. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Whipplewood Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
Whipplewood Advisors sold 90 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $2.71K.
Whipplewood Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2024 and held it in 4 quarters.
Whipplewood Advisors's Teva Pharmaceutical Industries Limited position peaked at $2.71K in Q1 2026.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.